Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement component C5b-9, also known as the membrane attack complex (MAC) or terminal complement complex (TCC), is a multi-protein structure formed during activation of the complement system. The MAC is assembled from complement proteins C5b, C6, C7, C8, and multiple copies of C9. Its primary function is to form transmembrane pores in target cell membranes, leading to cell lysis and death. It must be tightly regulated to avoid damage to host tissues. Dysregulation or deficiency can result in disease. Therapeutic targeting is possible.
Inhibition of C5 cleavage
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Component C5b-9 (MAC).